Decitabine and venetoclax for IDH1/2‐mutated acute myeloid leukemia
Sign Up to like & getrecommendations! Published in 2021 at "American Journal of Hematology"
DOI: 10.1002/ajh.26122
Abstract: Kaushansky K, Lichtman MA, Prchal JT, Levi M, Burns LJ, Linch DC, eds. Williams Hematology. 10th ed. New York: McGraw Hill; 2020:721-748. 5. Ho PJ, Wickramasinghe SN, Rees DC, Lee MJ, Eden A, Thein SL.… read more here.
Keywords: hematology; venetoclax idh1; idh1 mutated; acute myeloid ... See more keywords
Bladder Myeloid Sarcoma with TP53 mutated Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap syndrome: Response to Decitabine-Venetoclax regimen
Sign Up to like & getrecommendations! Published in 2022 at "Leukemia Research Reports"
DOI: 10.1016/j.lrr.2021.100286
Abstract: Myeloid sarcoma (MS) is a rare extramedullary blast proliferation of immature cells of myeloid origin. It is commonly associated with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or myeloproliferative neoplasm (MPN), and may precede, coincide… read more here.
Keywords: tp53 mutated; myeloproliferative neoplasm; decitabine venetoclax; myeloid sarcoma ... See more keywords